Literature DB >> 29399175

Effects of Wnt-1 blockade in DEN-induced hepatocellular adenomas of mice.

Argyrios Sklavos1, Theofilos Poutahidis2, Alexander Giakoustidis3, Kali Makedou4, Katerina Angelopoulou5, Alexander Hardas2, Paola Andreani6, Argyro Zacharioudaki7, George Saridis2, Thomas Goulopoulos1, Kalliopi Tsarea7, Maria Karamperi7, Vassilios Papadopoulos8, Vassilios Papanikolaou1, Apostolos Papalois7, Stavros Iliadis4, Satvinder Mudan3, Daniel Azoulay6, Dimitrios Giakoustidis1.   

Abstract

Recent evidence has suggested that downregulation of the Wnt/β-catenin signaling pathway may contribute to the development and growth of HCC. Consequently, elements of this pathway have begun to emerge as potential targets for improving outcomes of anti-HCC. Thus, the present study sought to examine the effects of Wnt-1 blockade using the classical diethylnitrosamine (DEN)-induced chemical carcinogenesis mouse model of HCC. The depletion of Wnt-1 using neutralizing antisera was done for ten consecutive days at the age of 9 months and mice were examined for the following 20 days. At that time, DEN-treated mice had multiple variably-sized hepatic cell adenomas. Anti-Wnt-1 was particularly potent in suppressing the expression of critical elements of the Wnt/β-catenin signaling pathway, such as β-catenin and Frizzled-1 receptor, however, not Dickkopf-related protein 1. This effect co-existed with the suppression of Cyclin D1, FOXM1, NF-κΒ and c-Jun commensurate with proliferation and apoptosis blockade in hepatocellular adenomas, and reduced Bcl-2 and c-Met in the serum of mice. Nonetheless, tumor size and multiplicity were found to be unaffected, suggesting that apoptosis may be equally important to proliferation in the context of counteracting DEN induced hepatocellular adenomas of mice.

Entities:  

Keywords:  Wnt-1; diethylnitrosamine; hepatocellular cancer; mice; β-catenin

Year:  2017        PMID: 29399175      PMCID: PMC5772790          DOI: 10.3892/ol.2017.7427

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  51 in total

1.  Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.

Authors:  Ming Quan; Jiujie Cui; Tian Xia; Zhiliang Jia; Dacheng Xie; Daoyan Wei; Suyun Huang; Qian Huang; Shaojiang Zheng; Keping Xie
Journal:  Cancer Res       Date:  2015-10-19       Impact factor: 12.701

Review 2.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

Review 3.  Piercing the armor of hepatobiliary cancer: Bcl-2 homology domain 3 (BH3) mimetics and cell death.

Authors:  Justin L Mott; Gregory J Gores
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

4.  Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.

Authors:  H Aydinlik; T D Nguyen; O Moennikes; A Buchmann; M Schwarz
Journal:  Oncogene       Date:  2001-11-22       Impact factor: 9.867

5.  Interleukin 18 binding protein ameliorates ischemia/reperfusion-induced hepatic injury in mice.

Authors:  Nikolaos Ouzounidis; Alexandros Giakoustidis; Theofilos Poutahidis; Katerina Angelopoulou; Stavros Iliadis; Antonis Chatzigiagkos; Argyro Zacharioudaki; Stamatis Angelopoulos; Apostolos Papalois; Vasilios Papanikolaou; Dimitrios Giakoustidis
Journal:  Liver Transpl       Date:  2016-02       Impact factor: 5.799

6.  The Applicability of a Human Immunohistochemical Panel to Mouse Models of Hepatocellular Neoplasia.

Authors:  Kenneth J Salleng; Frank L Revetta; Natasha G Deane; M Kay Washington
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

7.  Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.

Authors:  Qiujin Shen; Jia Fan; Xin-Rong Yang; Yexiong Tan; Weifeng Zhao; Yang Xu; Ning Wang; Yongdong Niu; Zheng Wu; Jian Zhou; Shuang-Jian Qiu; Ying-Hong Shi; Bin Yu; Ning Tang; Wei Chu; Min Wang; Jinhua Wu; Zhigang Zhang; Shengli Yang; Jianren Gu; Hongyang Wang; Wenxin Qin
Journal:  Lancet Oncol       Date:  2012-06-26       Impact factor: 41.316

Review 8.  Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system.

Authors:  Bob Thoolen; Robert R Maronpot; Takanori Harada; Abraham Nyska; Colin Rousseaux; Thomas Nolte; David E Malarkey; Wolfgang Kaufmann; Karin Küttler; Ulrich Deschl; Dai Nakae; Richard Gregson; Michael P Vinlove; Amy E Brix; Bhanu Singh; Fiorella Belpoggi; Jerrold M Ward
Journal:  Toxicol Pathol       Date:  2010-12       Impact factor: 1.902

9.  Apc tumor suppressor gene is the "zonation-keeper" of mouse liver.

Authors:  Samira Benhamouche; Thomas Decaens; Cécile Godard; Régine Chambrey; David S Rickman; Christophe Moinard; Mireille Vasseur-Cognet; Calvin J Kuo; Axel Kahn; Christine Perret; Sabine Colnot
Journal:  Dev Cell       Date:  2006-06       Impact factor: 12.270

10.  Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.

Authors:  Jie Hu; Aiwen Dong; Veronica Fernandez-Ruiz; Juanjuan Shan; Milosz Kawa; Eduardo Martínez-Ansó; Jesus Prieto; Cheng Qian
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

View more
  5 in total

1.  Anticancer effect of selenium/chitosan/polyethylene glycol/allyl isothiocyanate nanocomposites against diethylnitrosamine-induced liver cancer in rats.

Authors:  Cheng Li; Saleh H Salmen; Tahani Awad Alahmadi; Vishnu Priya Veeraraghavan; Krishna Mohan Surapaneni; Nandakumar Natarajan; Senthilkumar Subramanian
Journal:  Saudi J Biol Sci       Date:  2022-02-11       Impact factor: 4.052

2.  Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice.

Authors:  A S Arboatti; F Lambertucci; M G Sedlmeier; G Pisani; J Monti; M de L Álvarez; D E A Francés; M T Ronco; C E Carnovale
Journal:  Biomed Res Int       Date:  2018-04-23       Impact factor: 3.411

3.  HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice.

Authors:  Hara Afaloniati; Katerina Angelopoulou; Alexander Giakoustidis; Alexandros Hardas; Athanasios Pseftogas; Kali Makedou; Athanasios Gargavanis; Thomas Goulopoulos; Stavros Iliadis; Vasileios Papadopoulos; Apostolos Papalois; George Mosialos; Theofilos Poutahidis; Dimitrios Giakoustidis
Journal:  Onco Targets Ther       Date:  2020-06-15       Impact factor: 4.147

Review 4.  Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer.

Authors:  Yagmur Azbazdar; Mustafa Karabicici; Esra Erdal; Gunes Ozhan
Journal:  Front Cell Dev Biol       Date:  2021-01-21

5.  β-arrestin2 regulating β2-adrenergic receptor signaling in hepatic stellate cells contributes to hepatocellular carcinoma progression.

Authors:  Xiu-Qin Li; Wen-Ting Peng; Shan Shan; Jing-Jing Wu; Nan Li; Jia-Jia Du; Jia-Chang Sun; Ting-Ting Chen; Wei Wei; Wu-Yi Sun
Journal:  J Cancer       Date:  2021-10-28       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.